Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 14 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014Time to breast cancer relapse predicted by primary tumour characteristics, not lymph node involvementFitzpatrick, D.; Lai, C.; Parkyn, R.; Walters, D.; Humeniuk, V.; Walsh, D.
2014Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trialChow, E.; Meyer, R.; Chen, B.; van der Linden, Y.; Roos, D.; Hartsell, W.; Hoskin, P.; Wu, J.; Nabid, A.; Tissing-Tan, C.; Oei, B.; Babington, S.; Demas, W.; Wilson, C.; Wong, R.; Brundage, M.
2016A randomised controlled trial of perineural vs intravenous dexamethasone for foot surgeryDawson, R.; Mcleod, D.; Koerber, J.; Plummer, J.; Dracopoulos, G.
2014Preoperative factors predicting clinical outcome following laparoscopic fundoplicationStaehelin, A.; Zingg, U.; Devitt, P.; Esterman, A.; Smith, L.; Jamieson, G.; Watson, D.
2010Reduced femoral component subsidence with improved impaction grafting at revision hip arthroplastyHowie, D.; Callary, S.; Mc Gee, M.; Russell, N.; Solomon, L.; Closed Meeting of the International Hip Society (2009 : Minneapolis, MN, USA)
2011MLVA and phage typing as complementary tools in the epidemiological investigation of Salmonella enterica serovar typhimurium clustersRoss, I.; Davos, D.; Mwanri, L.; Raupach, J.; Heuzenroeder, M.
2011Morphometric evaluation of duodenal biopsies in celiac diseaseCummins, A.; Alexander, B.; Chung, A.; Teo, E.; Woenig, J.; Field, J.; Thompson, F.; Roberts-Thomson, I.
2012Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBurmeister, B.; Henderson, M.; Ainslie, J.; Fisher, R.; Di Iulio, J.; Smithers, B.; Hong, A.; Shannon, K.; Scolyer, R.; Carruthers, S.; Coventry, B.; Babington, S.; Duprat, J.; Hoekstra, H.; Thompson, J.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2011Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsKantarjian, H.; Giles, F.; Bhalla, K.; Pinilla-Ibarz, J.; Larson, R.; Gattermann, N.; Ottmann, O.; Hochhaus, A.; Radich, J.; Saglio, G.; Hughes, T.; Martinelli, G.; Kim, D.; Shou, Y.; Gallagher, N.; Blakesley, R.; Baccarani, M.; Cortes, J.; le Coutre, P.